Tirabrutinib is a BTK Inhibitor for Autoimmune Disorders and PCNSL Research
Bruton’s tyrosine kinase (BTK) is a key regulator of the B-cell receptor signaling pathway, and aberrant B-cell receptor (BCR) signaling has been implicated in the survival of malignant B-cells. However,…